Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Randomized phase II trial to compare two different hormone therapy regimens in preventing
endometrial cancer in women who have a genetic risk for hereditary nonpolyposis colon cancer.
Hormone therapy may prevent the development of endometrial cancer in women with a genetic
risk for hereditary nonpolyposis colon cancer. It is not yet known which hormone therapy
regimen is more effective in preventing endometrial cancer.